Hypoglim®

Glimepiride Tablet

Composition

Hypoglim® 1

Each tablet contains  Glimepiride USP 1 mg

Hypoglim® 2

Each tablet contains  Glimepiride USP 2 mg

Indications

Hypoglim® is as an adjunct to diet and exercise to lower the blood glucose in patients with non insulin-dependent (Type 2) diabetes mellitus (NIDDM) whose hyperglycaemia cannot be controlled by diet and exercise alone. Hypoglim® may be used concomitantly with metformin when diet, exercise, and glimepiride or metformin alone do not result in adequate glycaemic control. Hypoglim® is also indicated for use in combination with insulin to lower blood glucose in patients whose hyperglycaemia cannot be controlled by diet and exercise in conjunction with an oral hypoglycaemic agent. Combined use of glimepiride and insulin may increase the potential for hypoglycaemia.

PRESENTATION & PACKAGING

Hypoglim® 1      Yellow, round, flat, uncoated tablet
                           Blister strip pack of 10 s

Hypoglim® 2      Red, round,  flat, un-coated tablet
                          Blister strip pack of 10 s

For Precautions and Drug Interactions please consult full Product Information or write to us.

® - Registered Trade Mark of Quality Innovations and Pharmaceuticals (India) Pvt Ltd.

Disclaimer

 The drug information is intended for the use of a registered medical practitioner only. If you are not a medical professional, you should note that this document does not provide professional medical advice and is not intended to replace personal consultation with a qualified physician and should not be relied upon solely for final treatment decisions.Company reserves right to change Product presentation, display, capsule colors, tablet size,forms etc without prior notice.